-
SomaLogic, Amgen Enter Proteomic Profiling Pact
contractpharma
July 31, 2020
Will use SomaLogic’s proteomics technology to help advance Amgen’s drug discovery and development programs.
-
FDA Proposes New Rule on Reporting Requirement Under Right to Try Act
americanpharmaceuticalreview
July 30, 2020
The U.S. Food and Drug Administration (FDA) published the proposed rule, Annual Summary Reporting Requirements Under the Right to Try Act, that when finalized, will implement a statutory requirement for sponsors and manufacturers to provide an annual ...
-
Clinical trials for COVID-19 treatments show mixed results, says study
europeanpharmaceuticalreview
April 17, 2020
Despite some positive results from clinical trials for COVID-19 treatments, separate tests of the same therapies have not met primary endpoints.
-
Applied Biology to Launch COVID-19 Drug Discovery Platform
contractpharma
April 08, 2020
Based on breakthrough discovery made in collaboration with Brown University researchers.
-
Drug supply chain disruptions due to COVID-19 a very high concern: Poll
pharmaceutical-technology
April 08, 2020
Analysis of a poll conducted by Verdict to assess the impact of COVID-19 on the drug supply chain showed that 90% are either highly or partially concerned about the disruption.
-
Evotec and Ildong Enter Drug Development Collaboration
contractpharma
April 02, 2020
Evotec SE has entered into a strategic collaboration with South Korean pharma firm, Ildong Pharmaceutical, to accelerate the development of several of Ildong's proprietary projects through access to Evotec's INDiGO platform.
-
Pharma units in AP, Telengana to be exempted from lockdown
expresspharma
March 24, 2020
Government order exempts continuous process units such as pharmaceuticals, APIs etc.
-
Altasciences, Amador Bioscience Enter Strategic Collaboration
contractpharma
March 19, 2020
The partnership aims to expand world-class capabilities and resources to promote drug development in China and North America.
-
EMA announces measures to manage drug shortages as result of COVID-19
europeanpharmaceuticalreview
March 16, 2020
An EU Executive Steering Group will discuss how to address the impact of medicine shortages caused due to COVID-19, says the EMA.
-
Centre to expedite clearances to bulk drug projects to fight coronavirus
expresspharma
March 13, 2020
As cases of novel coronavirus rise, the Centre decided to expedite clearances to bulk drug projects by considering them ‘out of turn.’ In a notification ...